Elizabeth A Repasky (Anurag K Singh)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Topics

Endothelial Cells

Locally Advanced

Renal Cell Carcinoma

Ejection Fraction

Top Venues

Journal for immunotherapy of cancer

Cancer medicine

BJPsych advances

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Jacky Chow, Adil Khan, Madeline Gaudieri, Brianna J Wasik, Alexis Conway, Kah Teong Soh, Elizabeth A Repasky, Thomas Schwaab, Paul K Wallace, Scott I Abrams, Elizabeth A Repasky, Jason B Muhitch
Tumor and immune remodeling following radiotherapy in human renal cell carcinoma. Journal for immunotherapy of cancer 11 (4) (2023)
Jacky Chow, Adil Khan, Madeline Gaudieri, Brianna J Wasik, Alexis Conway, Kah Teong Soh, Elizabeth A Repasky, Thomas Schwaab, Paul K Wallace, Scott I Abrams, Elizabeth A Repasky, Jason B Muhitch
Tumor and immune remodeling following radiotherapy in human renal cell carcinoma. Journal for immunotherapy of cancer 11 (4) (2023)
Jacky Chow, Adil Khan, Madeline Gaudieri, Brianna J Wasik, Alexis Conway, Kah Teong Soh, Elizabeth A Repasky, Thomas Schwaab, Paul K Wallace, Scott I Abrams, Elizabeth A Repasky, Jason B Muhitch
Tumor and immune remodeling following radiotherapy in human renal cell carcinoma. Journal for immunotherapy of cancer 11 (4) (2023)
Jacky Chow, Adil Khan, Madeline Gaudieri, Brianna J Wasik, Alexis Conway, Kah Teong Soh, Elizabeth A Repasky, Thomas Schwaab, Paul K Wallace, Scott I Abrams, Elizabeth A Repasky, Jason B Muhitch
Tumor and immune remodeling following radiotherapy in human renal cell carcinoma. Journal for immunotherapy of cancer 11 (4) (2023)
Jacky Chow, Adil Khan, Madeline Gaudieri, Brianna J Wasik, Alexis Conway, Kah Teong Soh, Elizabeth A Repasky, Thomas Schwaab, Paul K Wallace, Scott I Abrams, Elizabeth A Repasky, Jason B Muhitch
Tumor and immune remodeling following radiotherapy in human renal cell carcinoma. Journal for immunotherapy of cancer 11 (4) (2023)
Jacky Chow, Adil Khan, Madeline Gaudieri, Brianna J Wasik, Alexis Conway, Kah Teong Soh, Elizabeth A Repasky, Thomas Schwaab, Paul K Wallace, Scott I Abrams, Elizabeth A Repasky, Jason B Muhitch
Tumor and immune remodeling following radiotherapy in human renal cell carcinoma. Journal for immunotherapy of cancer 11 (4) (2023)
Anurag K Singh, Udit Chatterjee, Cameron R MacDonald, Elizabeth A Repasky, Uriel Halbreich
Psychosocial stress and immunosuppression in cancer: what can we learn from new research? BJPsych advances 27 (3) (2021)
Sung Jun Ma, Lucas M Serra, Brian Yu, Austin J Bartl, Mark K Farrugia, Oluwadamilola T Oladeru, Elizabeth A Repasky
Evaluation of risk stratification using gene expression assays in patients with breast cancer receiving neoadjuvant chemotherapy. Breast cancer research and treatment 189 (3) (2021)
Jacky Chow, Nicholas C Hoffend, Scott I Abrams, Thomas Schwaab, Elizabeth A Repasky, Jason B Muhitch
Radiation induces dynamic changes to the T cell repertoire in renal cell carcinoma patients. Proceedings of the National Academy of Sciences of the United States of America 117 (38) (2020)
Alexis Platek, Michael Mix, Varun Chowdhry, Mark Farrugia, Michael A Lacombe, Jeffrey A Bogart, Luke Degraaf, Austin Iovoli, Hassan Arshad, Kimberly Wooten, Vishal Gupta, Wesley L Hicks, Mary E Platek, Seung S Hahn, Elizabeth A Repasky
Evaluation of radiation treatment volumes for unknown primaries of the head and neck in the era of FDG PET. PloS one 15 (4) (2020)
Gregory M Hermann, Austin J Iovoli, Alexis J Platek, Chong Wang, Austin Miller, Kristopher M Attwood, Daniel J Bourgeois, Elizabeth A Repasky
A single-institution, randomized, pilot study evaluating the efficacy of gabapentin and methadone for patients undergoing chemoradiation for head and neck squamous cell cancer. Cancer 126 (7) (2019)
Sung Jun Ma, Austin J Iovoli, Gregory M Hermann, Kavitha M Prezzano, Elizabeth A Repasky
Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I-II or unresected stage III pancreatic cancer. Cancer medicine 8 (9) (2019)
Sung Jun Ma, Gregory M Hermann, Kavitha M Prezzano, Lucas M Serra, Austin J Iovoli, Elizabeth A Repasky
Adjuvant chemotherapy followed by concurrent chemoradiation is associated with improved survival for resected stage I-II pancreatic cancer. Cancer medicine 8 (3) (2019)